Quanterix Corp (QTRX) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Quanterix Corp stock (QTRX) is currently trading at $3.96. Quanterix Corp PS ratio (Price-to-Sales) is 1.29. Analyst consensus price target for QTRX is $7.33. WallStSmart rates QTRX as Sell.
- QTRX PE ratio analysis and historical PE chart
- QTRX PS ratio (Price-to-Sales) history and trend
- QTRX intrinsic value — DCF, Graham Number, EPV models
- QTRX stock price prediction 2025 2026 2027 2028 2029 2030
- QTRX fair value vs current price
- QTRX insider transactions and insider buying
- Is QTRX undervalued or overvalued?
- Quanterix Corp financial analysis — revenue, earnings, cash flow
- QTRX Piotroski F-Score and Altman Z-Score
- QTRX analyst price target and Smart Rating
Quanterix Corp
📊 No data available
Try selecting a different time range
Smart Analysis
Quanterix Corp (QTRX) · 8 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales, price/book, revenue growth. Concerns around market cap and return on equity. Mixed signals suggest waiting for clearer direction before acting.
Quanterix Corp (QTRX) Key Strengths (4)
Trading below book value, meaning the market prices it less than net assets
83.47% of shares held by major funds and institutions
Paying $1.29 for every $1 of annual revenue
Strong revenue growth at 24.70% annually
Supporting Valuation Data
Quanterix Corp (QTRX) Areas to Watch (4)
Company is destroying shareholder value
Losing money on operations
Company is losing money with a negative profit margin
Micro-cap company with very limited liquidity and high volatility
Quanterix Corp (QTRX) Detailed Analysis Report
Overall Assessment
This company scores 40/100 in our Smart Analysis, earning a D grade. Out of 8 metrics analyzed, 4 register as strengths (avg 9.0/10) while 4 fall into concern territory (avg 0.8/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book, Institutional Own., Price/Sales. Valuation metrics including Price/Sales (1.29), Price/Book (0.68) suggest the stock is attractively priced. Growth metrics are encouraging with Revenue Growth at 24.70%.
The Bear Case
The primary concerns are Return on Equity, Operating Margin, Profit Margin. Profitability pressure is visible in Return on Equity at -34.30%, Operating Margin at -48.20%, Profit Margin at -77.10%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -34.30% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 24.70% strong but requiring continuation.
Risk Considerations
Based on the metric profile, this is a higher risk investment. Strengths and concerns are roughly balanced. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Operating Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
QTRX Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
QTRX's Price-to-Sales ratio of 1.29x trades at a deep discount to its historical average of 17.4x (0th percentile). The current valuation is 98% below its historical high of 57.03x set in Dec 2017, and 0% above its historical low of 1.29x in Mar 2026. Over the past 12 months, the PS ratio has compressed from ~2.3x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for Quanterix Corp (QTRX) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Quanterix Corp is a strong growth company balancing expansion with improving profitability. Revenue reached 139M with 25% growth year-over-year. The company is currently unprofitable, posting a -77.1% profit margin.
Key Findings
Debt-to-equity ratio of 0.13 indicates a conservative balance sheet with 38M in cash.
The company is unprofitable with a -77.1% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -17M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Growth sustainability: can Quanterix Corp maintain 25%+ revenue growth, or will competition slow it down?
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Quanterix Corp.
Bottom Line
Quanterix Corp offers an attractive blend of growth (25% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(49 last 3 months)
| Insider | Type | Shares |
|---|---|---|
SRIRAM, VANDANA Chief Financial Officer | Sell | -4,395 |
| Insider | Type | Shares |
|---|---|---|
TOLOUE, MASOUD Director, President & CEO | Sell | -258 |
Data sourced from SEC Form 4 filings
Last updated: 11:52:44 AM
About Quanterix Corp(QTRX)
NASDAQ
HEALTHCARE
MEDICAL DEVICES
USA
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the regions from Asia Pacific. The company is headquartered in Billerica, Massachusetts.